Literature DB >> 21695598

Sub-optimal asthma control in teenagers in the midland region of Ireland.

I Kelly1, P Fitzpatrick.   

Abstract

BACKGROUND: Internationally, many children with asthma are not attaining achievable asthma control. AIMS: To examine the prevalence of asthma in teenagers in four midland counties, their asthma control and the barriers, if any, to gaining control of asthma.
METHODOLOGY: International Study of Asthma and Allergies in Children (ISAAC) methodology was used in a survey of Junior Cycle Year 2 second-level students.
RESULTS: The prevalence of "wheeze ever" was 49.8%, "wheeze in the last 12 months" was 32.6% and "asthma ever" was 23.5%. Of teenagers with current asthma, 96% had evidence of sub-optimal asthma control during the previous year. For the majority of the teenagers with asthma, treatment was not guideline concordant; infrequent lung function testing, insufficient review after acute care and poor use of written asthma action plans. Barriers included lack of awareness of need for treatment.
CONCLUSIONS: If asthma guidelines are implemented fully, these children may experience better health.

Entities:  

Mesh:

Year:  2011        PMID: 21695598     DOI: 10.1007/s11845-011-0725-1

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  10 in total

Review 1.  The global burden of asthma: executive summary of the GINA Dissemination Committee report.

Authors:  Matthew Masoli; Denise Fabian; Shaun Holt; Richard Beasley
Journal:  Allergy       Date:  2004-05       Impact factor: 13.146

2.  Diet and asthma in Dutch school children (ISAAC-2).

Authors:  C Tabak; A H Wijga; G de Meer; N A H Janssen; B Brunekreef; H A Smit
Journal:  Thorax       Date:  2005-10-21       Impact factor: 9.139

3.  Rising prevalence of asthma but declining wheeze in teenagers (1995-2003): ISAAC protocol.

Authors:  P J Manning; P Goodman; A O'Sullivan; L Clancy
Journal:  Ir Med J       Date:  2007 Nov-Dec

4.  Treatment regimens and health care utilization in children with persistent asthma symptoms.

Authors:  H Lorrie Yoos; Harriet Kitzman; Jill S Halterman; Charles Henderson; Kimberly Sidora-Arcoleo; Ann McMullen
Journal:  J Asthma       Date:  2006 Jun-Jul       Impact factor: 2.515

5.  Asthma treatment needs: a comparison of patients' and health care professionals' perceptions.

Authors:  Michael E Hyland; Elisabeth Ståhl
Journal:  Clin Ther       Date:  2004-12       Impact factor: 3.393

6.  Asthma control and management: a patient's perspective.

Authors:  P Manning; P Greally; E Shanahan
Journal:  Ir Med J       Date:  2005 Nov-Dec

7.  Clinical diagnosis of current asthma: predictive value of respiratory symptoms in the SAPALDIA study. Swiss Study on Air Pollution and Lung Diseases in Adults.

Authors:  D Sistek; J M Tschopp; C Schindler; M Brutsche; U Ackermann-Liebrich; A P Perruchoud; P Leuenberger
Journal:  Eur Respir J       Date:  2001-02       Impact factor: 16.671

8.  Documenting asthma severity: do we get it right?

Authors:  Sandra Braganza; Iman Sharif; Philip O Ozuah
Journal:  J Asthma       Date:  2003-09       Impact factor: 2.515

Review 9.  Poor asthma control in children: evidence from epidemiological surveys and implications for clinical practice.

Authors:  P M Gustafsson; L Watson; K J Davis; K F Rabe
Journal:  Int J Clin Pract       Date:  2006-03       Impact factor: 2.503

10.  Symptom perception in childhood asthma: how accurate are children and their parents?

Authors:  H Lorrie Yoos; Harriet Kitzman; Ann McMullen; Kimberly Sidora
Journal:  J Asthma       Date:  2003-02       Impact factor: 2.515

  10 in total
  1 in total

1.  Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI™ suppresses TNF-α production by mouse macrophages and peripheral blood mononuclear cells from asthma patients.

Authors:  Changda Liu; Nan Yang; Ying Song; Lixin Wang; Jiachen Zi; Shuwei Zhang; David Dunkin; Paula Busse; David Weir; Jody Tversky; Rachel L Miller; Joseph Goldfarb; Jixun Zhan; Xiu-Min Li
Journal:  Int Immunopharmacol       Date:  2015-05-21       Impact factor: 4.932

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.